BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34086889)

  • 1. GPR34 activation potentially bridges lymphoepithelial lesions to genesis of salivary gland MALT lymphoma.
    Korona B; Korona D; Zhao W; Wotherspoon AC; Du MQ
    Blood; 2022 Apr; 139(14):2186-2197. PubMed ID: 34086889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel
    Moody S; Thompson JS; Chuang SS; Liu H; Raderer M; Vassiliou G; Wlodarska I; Wu F; Cogliatti S; Robson A; Ashton-Key M; Bi Y; Goodlad J; Du MQ
    Haematologica; 2018 Aug; 103(8):1329-1336. PubMed ID: 29674500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.
    Ansell SM; Akasaka T; McPhail E; Manske M; Braggio E; Price-Troska T; Ziesmer S; Secreto F; Fonseca R; Gupta M; Law M; Witzig TE; Dyer MJ; Dogan A; Cerhan JR; Novak AJ
    Blood; 2012 Nov; 120(19):3949-57. PubMed ID: 22966169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR6 activation links innate immune responses to mucosa-associated lymphoid tissue lymphoma development.
    Korona B; Korona D; Zhao W; Wotherspoon AC; Du MQ
    Haematologica; 2022 Jun; 107(6):1384-1396. PubMed ID: 35142152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type.
    Carbone A; Gloghini A; Ferlito A
    Ann Otol Rhinol Laryngol; 2000 Dec; 109(12 Pt 1):1170-5. PubMed ID: 11130833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and up-regulates GPR34.
    Baens M; Finalet Ferreiro J; Tousseyn T; Urbankova H; Michaux L; de Leval L; Dierickx D; Wolter P; Sagaert X; Vandenberghe P; De Wolf-Peeters C; Wlodarska I
    Haematologica; 2012 Feb; 97(2):184-8. PubMed ID: 22058210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPR34 as a lysophosphatidylserine receptor.
    Makide K; Aoki J
    J Biochem; 2013 Apr; 153(4):327-9. PubMed ID: 23389307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoepithelial lesions in the salivary glands of primary Sjögren's syndrome patients: the perfect storm?
    Pringle S; Verstappen GM; van Ginkel MS; Nakshbandi U; Girigoria Z; Bootsma H; van der Vegt B; Kroese FGM
    Clin Exp Rheumatol; 2022 Dec; 40(12):2434-2442. PubMed ID: 36226606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization.
    Barone F; Bombardieri M; Rosado MM; Morgan PR; Challacombe SJ; De Vita S; Carsetti R; Spencer J; Valesini G; Pitzalis C
    J Immunol; 2008 Apr; 180(7):5130-40. PubMed ID: 18354239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary gland lymphoid infiltrates associated with lymphoepithelial lesions: a clinicopathologic, immunophenotypic, and genotypic study.
    Quintana PG; Kapadia SB; Bahler DW; Johnson JT; Swerdlow SH
    Hum Pathol; 1997 Jul; 28(7):850-61. PubMed ID: 9224756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position.
    Kitamura H; Makide K; Shuto A; Ikubo M; Inoue A; Suzuki K; Sato Y; Nakamura S; Otani Y; Ohwada T; Aoki J
    J Biochem; 2012 May; 151(5):511-8. PubMed ID: 22343749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the apoptosis-suppressing oncoprotein bcl-2 in salivary gland lymphoma.
    Takahashi H; Fujita S; Shibata Y; Okabe H; Hideshima K; Tsuda N
    Pathol Res Pract; 1998; 194(3):163-70. PubMed ID: 9587934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR34 in spinal microglia exacerbates neuropathic pain in mice.
    Sayo A; Konishi H; Kobayashi M; Kano K; Kobayashi H; Hibi H; Aoki J; Kiyama H
    J Neuroinflammation; 2019 Apr; 16(1):82. PubMed ID: 30975169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for lysophosphatidylserine recognition by GPR34.
    Izume T; Kawahara R; Uwamizu A; Chen L; Yaginuma S; Omi J; Kawana H; Hou F; Sano FK; Tanaka T; Kobayashi K; Okamoto HH; Kise Y; Ohwada T; Aoki J; Shihoya W; Nureki O
    Nat Commun; 2024 Feb; 15(1):902. PubMed ID: 38326347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of primary gastric lymphomas according to histologic features.
    Hsi ED; Eisbruch A; Greenson JK; Singleton TP; Ross CW; Schnitzer B
    Am J Surg Pathol; 1998 Jan; 22(1):17-27. PubMed ID: 9422312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for ligand recognition and signaling of the lysophosphatidylserine receptors GPR34 and GPR174.
    Liu G; Li X; Wang Y; Zhang X; Gong W
    PLoS Biol; 2023 Dec; 21(12):e3002387. PubMed ID: 38048360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjögren's Syndrome.
    Nishimura M; Miyajima S; Okada N
    J Dermatol; 2000 Jul; 27(7):450-2. PubMed ID: 10935342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid proliferations of the salivary glands.
    Harris NL
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S94-103. PubMed ID: 9894474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pattern recognition in the differential diagnosis of salivary lymphoepithelial lesions].
    Ihrler S; Adam P; Guntinas-Lichius O; Harrison JD; Weiler C
    Pathologe; 2009 Nov; 30(6):432-41. PubMed ID: 19813014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.